Company Overview of SARcode Bioscience Inc.
SARcode Bioscience Inc. develops small molecule compounds for the treatment of ophthalmic and dermatologic inflammations caused due to T-cells. It involves in the development of a lymphocyte function-associated antigen-antagonists for the treatment of T-cell mediated inflammatory diseases. The company was founded in 2006 and is based in Brisbane, California. As of April 17, 2013, SARcode Bioscience Inc. operates as a subsidiary of Shire plc.
1000 Marina Boulevard
Brisbane, CA 94005
Founded in 2006
Key Executives for SARcode Bioscience Inc.
Similar Private Companies By Industry
|Human Genome Sciences Inc.||United States|
|Genetic Medisyn Corp.||United States|
|Eleison Pharmaceuticals Inc.||United States|
|BioTransplant Incorporated||United States|
|Prexa Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact SARcode Bioscience Inc., please visit www.sarcode.com. Company data is provided by Capital IQ. Please use this form to report any data issues.